Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 100.55M $100.55M March 31, 2015
T. Rowe Price Associates 28.30M $5.40B Dec. 31, 2015
Capital Research Global Investors^ 27.60M $5.27B Dec. 31, 2015
FMR 14.88M $2.84B Dec. 31, 2015
Vanguard 12.97M $2.47B Dec. 31, 2015
STATE STREET CORPORATION 8.82M $1.68B Dec. 31, 2015
Jennison Associates 7.35M $1.40B Dec. 31, 2015
Baker Bros. Advisors 6.54M $1.25B Dec. 31, 2015
Sands Capital Management 6.06M $1.16B Dec. 31, 2015
Wells Fargo & Company 5.98M $1.14B Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 5.59M $1.07B Dec. 31, 2015
VIKING GLOBAL INVESTORS 5.54M $511.47M June 30, 2013
JPMORGAN CHASE & CO 5.31M $959.92M June 30, 2015
Ameriprise Financial 5.21M $992.95M Dec. 31, 2015

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Sept. 30, 2011 6.28M $402.57M